Mapping Genetic Drivers of Prostate Cancer Treatment Resistance

The Future of Prostate Cancer Treatment: Breaking the Cycle of Therapy Resistance Prostate cancer remains a formidable challenge in global health, with its complexity evolving alongside the very treatments designed to combat it. A recent review published in the journal Research (DOI: 10.34133/research.1128) sheds new light on the mechanisms driving therapy resistance, providing a roadmap … Read more

Fewer radiotherapy sessions for prostate cancer show minimal side effects

The Shift Toward Ultra-Hypofractionated Radiotherapy For decades, the standard approach to treating localized prostate cancer involved a grueling schedule of daily hospital visits. In many countries, the benchmark has been five radiotherapy sessions. However, a significant shift is occurring toward “hypofractionation”—delivering larger doses of radiation in fewer sessions. Recent findings from the HERMES study, presented … Read more

UIC researchers develop anti-cancer therapy inspired by bacteria in tumors

Starving the Tumor: The Rise of Bacterial-Inspired Cancer Therapies For decades, the war on cancer has largely focused on attacking the cell’s ability to divide. But, a paradigm shift is occurring. Researchers are now looking at how to “starve” cancer by targeting its energy source: the mitochondria. View this post on Instagram about Starving the … Read more

Scientists discover BRCA links to head and neck cancer risks

Expanding the Horizon of Personalized Oncology For years, the medical community has viewed BRCA1 and BRCA2 mutations primarily through the lens of breast and ovarian cancer risk. However, a groundbreaking shift is occurring in how we understand genetic susceptibility. Recent research led by the RIKEN Center for Integrative Medical Sciences (IMS) in Japan is pushing … Read more

Prostate cancer patients recover faster with TULSA than robotic surgery

Minimally Invasive Prostate Cancer Treatment: A New Era of Faster Recovery? Men diagnosed with localized, intermediate-risk prostate cancer may soon have a new option that prioritizes a quicker return to daily life. A recent randomized clinical trial, presented at the 2026 Society of Interventional Radiology (SIR) Annual Scientific Meeting, suggests that MRI-guided, transurethral ultrasound ablation … Read more

Estradiol patches as effective as injections for locally advanced prostate cancer

Prostate Cancer Treatment: Patches Offer Hope for Fewer Side Effects Men diagnosed with locally advanced prostate cancer may soon have a more convenient and potentially less debilitating treatment option. A recent clinical trial led by University College London (UCL) researchers has demonstrated that hormone patches are as effective as traditional injections in controlling the disease, … Read more

Systematic review identifies stress-induced biological triggers in oncology

The Silent Threat: How Chronic Stress is Rewriting the Rules of Cancer Care Stress is an unwelcome, yet constant, companion for anyone facing a cancer diagnosis. But emerging research reveals it’s far more than just an emotional burden. Chronic stress is increasingly recognized as a biological factor that can influence cancer progression, treatment response, and … Read more

International urology conference showcases advancements in prostate cancer diagnostics

Prostate Cancer Screening: A New Era of Precision and Reduced Anxiety The landscape of prostate cancer screening is rapidly evolving, with advancements showcased at the European Association of Urology Congress (EAU26) in London. From increasingly accurate diagnostic tools to strategies for minimizing patient anxiety, the focus is shifting towards more personalized and effective care. The … Read more

FOXJ1 gene may drive resistance to taxane chemotherapy in advanced prostate cancer

Prostate Cancer Treatment Breakthrough: FOXJ1 Gene Holds Key to Overcoming Chemotherapy Resistance A newly discovered link between the FOXJ1 gene and resistance to taxane chemotherapy is offering fresh hope for patients battling advanced prostate cancer. Researchers at Weill Cornell Medicine and Beth Israel Deaconess Medical Center have identified FOXJ1 as a potential driver of drug … Read more

Global breast cancer burden rising fastest in low-income countries

Breast Cancer Cases Projected to Surge Globally: A Looming Health Crisis Despite advancements in treatment, a new analysis from the Global Burden of Disease Study Breast Cancer Collaborators paints a concerning picture: global breast cancer cases are predicted to increase by a third, rising from 2.3 million in 2023 to over 3.5 million in 2050. … Read more